Tuesday, February 24, 2026
HomeTagsHealthcare

Healthcare

RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy (NK)

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, announced the release of the THUNDERBEAT Open...

Centers for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia’s IMMray PanCan-d test

Immunovia AB (NASDAQ Stockholm: IMMNOV) announced, that the Centers for Medicare & Medicaid Services (CMS) published a preliminary payment determination implying a price of...

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...

Ionis Provides Update on Development Program Evaluating PCSK9 Antisense Medicine

Ionis Pharmaceuticals, Inc. announced that topline results from the Phase 2b SOLANO study in patients with hypercholesterolemia demonstrated that 60mg of ION449 (AZD8233) administered...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics